The sales of anticoagulant are expected to reach US$ 30 Bn by the end of 2021. As per the study, demand will continue rising, expanding over 2x to be valued at US$ 65 Bn by the end of the 2021-2031 assessment period.
Download FREE Sample Copy of This Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=4335?pk
This research highlights the key trends that hold the potential to influence the growth of the anticoagulants market, along with crucial macroeconomic and microeconomic growth indicators. This insightful report offers the key dynamics, and their impact on the value chain, which are projected to influence the future growth of the anticoagulants market.
The study also includes a detailed section dedicated to impeders that could challenge the growth of players in the anticoagulants market. The report unfolds lucrative opportunities for market players, which they can leverage to consolidate their position in the global market. With a view of aiding stakeholders in the anticoagulants market, the study comprises a detailed section on the competition analysis. The study offers a dashboard view of the report, with a comprehensive comparison of players operating in the anticoagulants market, based on total revenue, market presence, and key developments. Besides this, the recent developments and key strategies of players in the anticoagulants market have also been included in this comprehensive study.
Key Companies
- Bayer AG
- Boehringer Ingelheim International GmbH
- Bristol-Myers Squibb Company
- Daiichi Sankyo Company Ltd.
- Sanofi SA
- Johnson & Johnson
Anticoagulants Market – Assessment of Key Segments
Authors of the report have segmented the anticoagulants market into key categories in order to study the market at a microscopic level. The key segments considered while bifurcating the anticoagulants market include:
Besides laying focus on the aforementioned key segments, the report also studies the anticoagulants market at a country level, to recalibrate the underlying opportunities available for players in the anticoagulants market for the forecast period. Among all the estimated data, the report also includes Y-o-Y growth projections, which can help market players in comprehending the precise trajectory at which the anticoagulants market has been growing.
Key companies profiled in this exclusive study include Bayer AG, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Daiichi Sankyo Company Limited, Sanofi, and Johnson & Johnson Service. The study provides crucial insights into the finances of these companies, along with their product portfolios, key strategies, and SWOT analysis. In addition, the study also discusses Porter’s Five Forces, which highlights the threats of substitutes, purchasing power of buyers and suppliers, and intensity of competition present in the anticoagulants market during the forecast period (2020-2026).
Key Segments Covered
- By Drug Class
- Factor X Inhibitor (NOAC/DOAC) Anticoagulants
- Heparin Anticoagulants
- Direct Thrombin Inhibitor Anticoagulants
- Vitamin K Antagonist Anticoagulants
- By Indication
- Deep Vein Thrombosis
- Pulmonary Embolism
- Atrial Fibrillation & Heart Attack
- Other Indications
- By Route of Administration
- Oral Anticoagulants
- Injectable Anticoagulants
- By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- By Region
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East & Africa
